The Quarterback Trial: Reduced Dose Radiotherapy for HPV+ Oropharynx Cancer

NCT01706939 · clinicaltrials.gov ↗

PHASE3

Phase

ACTIVE_NOT_RECRUITING

Status

23

Enrollment

OTHER

Sponsor class

Conditions

Squamous Cell Carcinomas

Interventions

RADIATION: Reduced Dose Radiation
RADIATION: Standard Dose Radiation
DRUG: Carboplatin

Sponsor

Icahn School of Medicine at Mount Sinai

Collaborators

[object Object]
[object Object]